Estrogen, Astrocyte Reactivity, and Sex Differences in Alzheimer's Disease
阿尔茨海默病中的雌激素、星形胶质细胞反应性和性别差异
基本信息
- 批准号:10662993
- 负责人:
- 金额:$ 194.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAccelerationAgeAge MonthsAgonistAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmericanAndrogensAnimalsAromataseAstrocytesAutopsyBehavioralBindingBiochemicalBioinformaticsBiologicalBrainCell SeparationChIP-seqChromatinClinicalCognitionCognitiveDataData SetDependovirusDevelopmentEpigenetic ProcessEstradiolEstrogen Receptor alphaEstrogen ReceptorsEstrogen deficiencyEstrogensExhibitsFemaleGene ExpressionGenesGenomicsGlial Fibrillary Acidic ProteinGonadal structureHippocampusHormonesHumanImmunofluorescence ImmunologicImpairmentKnock-outKnowledge PortalLabelLinkLoxP-flanked alleleMagnetismMeasuresMediatingMedical RecordsMemoryMemory LossMemory impairmentMicroinjectionsModelingMolecularMorphologyMusNerve DegenerationNeuronsOutcomePathway interactionsPerimenopausePhenotypePostmenopausePrevention strategyProductionProteinsRecordsReportingResearchRiskRoleSeveritiesSex DifferencesSignal TransductionSmall Interfering RNASynapsesTestingTissuesTransgenic OrganismsWestern BlottingWomanage relatedagedanalogclinically relevantconditional knockoutenzyme activitygenome-wide analysishuman dataknock-downmalemenmouse modelneuron lossneuropathologyneuroprotectionneurotoxicitynew therapeutic targetnovelnovel therapeutic interventionolder womenpharmacologicpreventpromotersexsingle nucleus RNA-sequencingsynaptogenesistheoriestranscriptometranscriptome sequencing
项目摘要
SUMMARY
Nearly two-thirds of the more than 6 million Americans living with Alzheimer’s disease (AD) are women; however,
the molecular mechanisms underlying this sex difference in AD vulnerability are largely unknown. Prior research
has reported lower levels of estrogen in the brain of women with AD. The long-term objective of this application
is to define the role of estrogen deficiency in the observed sex-specific difference in AD vulnerability. Aromatase,
which converts androgens to estrogens, is mainly expressed in the brain and gonads of mice. We demonstrated
that knockout of aromatase locally in the mouse brain (bArKO) or totally in whole body (tArKO) causes sex-
specific memory deficits in old female mice. This phenotype is more severe in tArKO mice with estrogen
deficiency throughout the body vs. bArKO mice with estrogen deficiency only in the brain. Estrogen exerts its
biological action via binding to estrogen receptors (ERs). Treatment with the selective ERα agonist
propylpyrazoletriol rescued memory loss in female tArKO mice. Old female tArKO, but not old male tArKO mice,
exhibited fewer neurons in the hippocampus compared to wild-type littermates. RNA-seq, qPCR, and
immunofluorescence analyses of the hippocampus from young or old bArKO mice of both sexes revealed
astrocyte reactivity and related gene expression and morphologic changes only in old female bArKO mice. These
data suggested a novel mechanism in which estrogen deficiency leads to astrocyte reactivity. We hypothesize
that deficiency of estrogen/ERα signaling in the brain after menopause causes sex-specific astrocyte reactivity,
resulting in AD-related neuropathology and memory loss, leading to increased AD vulnerability in females. To
ascertain the mechanisms connecting estrogen deficiency in the brain to sex differences in AD vulnerability, we
propose the following aims: 1. Determine whether reversal of aromatase deletion and estrogen deficiency
reduces astrocyte reactivity and protects against neurodegeneration and memory loss. We will use transgenic
and pharmacological approaches to restore brain aromatase expression or estrogen action in bArKO and tArKO
mice at different ages. The estrogen/ERα-mediated genomic mechanisms responsible for the suppression of
sex-specific hippocampal astrocyte reactivity, neurodegeneration, and memory loss will be determined using
integrative genome-wide analyses employing single-nucleus (sn) RNA-seq, ERα-ChIP-seq, and snATAC-seq on
freshly isolated hippocampal astrocytes. 2. Determine whether conditional knockout of ERα in hippocampal
astrocytes of APPNL-G-F mice accelerates astrocyte reactivity, memory loss, and AD-related neuropathology. In
parallel, we will assess estrogen levels, expression of aromatase and ERα, and sex-specific expression of
reactive astrocyte-related genes in existing human datasets and postmortem hippocampal tissues and their
correlation with the severity of AD pathology and memory deficits in medical records of women and age-matched
men with AD. We expect that the findings from the proposed studies will identify new drug targets and lead to
novel therapeutical strategies for the prevention and treatment of AD.
总结
在600多万患有阿尔茨海默病(AD)的美国人中,近三分之二是女性;然而,
AD易感性性别差异的分子机制在很大程度上是未知的。先前的研究
曾报道女性AD患者大脑中雌激素水平较低。本申请的长期目标是
目的是确定雌激素缺乏在观察到的AD易感性性别特异性差异中的作用。芳香酶,
其将雄激素转化为雌激素,主要在小鼠的脑和性腺中表达。我们证明
敲除小鼠大脑中的局部芳香化酶(bArKO)或整个身体中的芳香化酶(tArKO)会导致性行为-
老年雌性小鼠的特定记忆缺陷。这种表型在具有雌激素的tArKO小鼠中更严重
在整个身体中缺乏雌激素的bArKO小鼠与仅在大脑中缺乏雌激素的bArKO小鼠相比。雌激素发挥其
通过结合雌激素受体(ER)发挥生物学作用。选择性ERα激动剂治疗
丙基吡唑三醇挽救了雌性tArKO小鼠的记忆丧失。年老的雌性tArKO,但不是年老的雄性tArKO小鼠,
与野生型同窝仔相比,在海马体中表现出较少的神经元。RNA-seq、qPCR和
对来自两种性别的年轻或年老bArKO小鼠的海马的免疫荧光分析显示,
星形胶质细胞反应性和相关基因表达以及仅在老年雌性bArKO小鼠中的形态学变化。这些
数据提示了一种新的机制,其中雌激素缺乏导致星形胶质细胞反应性。我们假设
绝经后大脑中雌激素/ERα信号的缺乏会导致性别特异性星形胶质细胞反应,
导致AD相关的神经病理学和记忆丧失,导致女性AD易感性增加。到
为了确定大脑中雌激素缺乏与AD易感性性别差异之间的联系机制,
提出以下目标:1.确定是否逆转芳香化酶缺失和雌激素缺乏
减少星形胶质细胞的反应性,防止神经变性和记忆丧失。我们将使用转基因
以及恢复bArKO和tArKO脑芳香酶表达或雌激素作用的药理学方法
不同年龄的小鼠。雌激素/ERα介导的基因组机制负责抑制
性别特异性海马星形胶质细胞反应性、神经变性和记忆丧失将使用
使用单核(sn)RNA-seq、ERα-ChIP-seq和snATAC-seq进行全基因组整合分析,
新鲜分离的海马星形胶质细胞。2.确定海马ERα的条件性敲除是否
APPNL-G-F小鼠的星形胶质细胞加速星形胶质细胞反应性、记忆丧失和AD相关的神经病理学。在
同时,我们将评估雌激素水平,芳香化酶和ERα的表达,
现有人类数据集和死后海马组织中的反应性星形胶质细胞相关基因及其
与AD病理严重程度和女性和年龄匹配的医疗记录中的记忆缺陷相关
男性AD我们希望拟议研究的结果将确定新的药物靶点,
用于预防和治疗AD的新治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Serdar E. Bulun其他文献
グラビア・目で見る遺伝子異常と婦人科内分泌疾患―早発卵巣不全―
凹印/可见基因异常与妇科内分泌疾病 - 卵巢早衰 -
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Masanori Ono;Tetsuo Maruyama;Mamoru Tanaka;Daisuke Aoki;Serdar E. Bulun;河村和弘・佐藤可野・鈴木直 - 通讯作者:
河村和弘・佐藤可野・鈴木直
STEROYL-CoA DESATURASE INHIBITION IS ASSOCIATED WITH DECREASED UTERINE LEIOMYOMA CELL VIABILITY
- DOI:
10.1016/j.fertnstert.2023.08.600 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
Allison S. Komorowski;Azna Zuberi;John S. Coon V;Melania Anton;Serdar E. Bulun;Ping Yin - 通讯作者:
Ping Yin
Therapeutic targeting of the tryptophan-kynurenine-aryl hydrocarbon receptor pathway with apigenin in MED12-mutant leiomyoma cells
芹菜素对 MED12 突变型平滑肌瘤细胞中色氨酸-犬尿氨酸-芳烃受体通路的治疗靶向作用
- DOI:
10.1038/s41417-025-00881-0 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:5.000
- 作者:
Takashi Iizuka;Azna Zuberi;Helen Wei;John S. Coon V;Melania Lidia Anton;Kadir Buyukcelebi;Mazhar Adli;Serdar E. Bulun;Ping Yin - 通讯作者:
Ping Yin
Role of WNT/CTNNB1 pathway in differentiation of human induced pluced pluripotent stem cells to endometrial stroma-like cells
WNT/CTNNB1通路在人诱导多能干细胞向子宫内膜基质样细胞分化中的作用
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Kaoru Miyazaki;Matthew T. Dyson;John S. Coon;Tetsuo Maruyama;Serdar E. Bulun - 通讯作者:
Serdar E. Bulun
Transcriptome analysis of endometrial stroma-like ofganoids differentiated from human induced pluripotent stem cells
人诱导多能干细胞分化的子宫内膜基质样细胞的转录组分析
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Kaoru Miyazaki ;Matthew T. Dyson ;John S. Coon;Maruyama T;Serdar E. Bulun - 通讯作者:
Serdar E. Bulun
Serdar E. Bulun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Serdar E. Bulun', 18)}}的其他基金
Environmental Pollutants and AHR pathway in Uterine Leiomyoma
环境污染物与子宫平滑肌瘤的 AHR 通路
- 批准号:
10567192 - 财政年份:2022
- 资助金额:
$ 194.24万 - 项目类别:
Epigenome, MED12 and Progesterone Action in Uterine Leiomyomas
表观基因组、MED12 和孕酮在子宫平滑肌瘤中的作用
- 批准号:
10396486 - 财政年份:2019
- 资助金额:
$ 194.24万 - 项目类别:
Epigenome, MED12 and Progesterone Action in Uterine Leiomyomas
表观基因组、MED12 和孕酮在子宫平滑肌瘤中的作用
- 批准号:
10153842 - 财政年份:2019
- 资助金额:
$ 194.24万 - 项目类别:
相似海外基金
Epigenetic Age Acceleration Impacts Racial and Neighborhood Disparities in Chronic Low Back Pain
表观遗传年龄加速影响慢性腰痛的种族和社区差异
- 批准号:
10431156 - 财政年份:2022
- 资助金额:
$ 194.24万 - 项目类别:
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease
镰状细胞病的表观遗传年龄加速和精神神经症状
- 批准号:
10594523 - 财政年份:2022
- 资助金额:
$ 194.24万 - 项目类别:
Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health
生命早期心血管疾病危险因素、表观遗传年龄加速和阿尔茨海默病相关的大脑健康
- 批准号:
10706044 - 财政年份:2022
- 资助金额:
$ 194.24万 - 项目类别:
The pathway from prenatal pregnancy-specific anxiety to offspring ADHD through epigenetic age acceleration DNA methylation and moderators to target intervention: Partner social support
通过表观遗传年龄加速 DNA 甲基化和调节因子从产前妊娠特异性焦虑到后代 ADHD 的途径:伴侣社会支持
- 批准号:
475968 - 财政年份:2022
- 资助金额:
$ 194.24万 - 项目类别:
Studentship Programs
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease
镰状细胞病的表观遗传年龄加速和精神神经症状
- 批准号:
10449461 - 财政年份:2022
- 资助金额:
$ 194.24万 - 项目类别:
Functional genetic analysis of epigenetic age acceleration and the regulatory landscape of the methylome
表观遗传年龄加速的功能遗传分析和甲基化组的调控景观
- 批准号:
10674263 - 财政年份:2022
- 资助金额:
$ 194.24万 - 项目类别:
Perinatal Maternal Anxiety and Offspring ADHD Symptoms: Mediation Through Epigenetic Age Acceleration DNA Methylation
围产期母亲焦虑和后代 ADHD 症状:通过表观遗传年龄加速 DNA 甲基化进行调节
- 批准号:
467256 - 财政年份:2021
- 资助金额:
$ 194.24万 - 项目类别:
Studentship Programs
CAREER: Understanding the Role of Cu-Containing Secondary Phase Particles in Enhancing the Resistance to the Environmental Acceleration to Fatigue in Age-Hardenable Al Alloys
事业:了解含铜第二相颗粒在增强时效硬化铝合金的环境加速疲劳抵抗力方面的作用
- 批准号:
1943870 - 财政年份:2020
- 资助金额:
$ 194.24万 - 项目类别:
Continuing Grant
Breast Cancer Risk Factors and Epigenetic Age Acceleration
乳腺癌危险因素和表观遗传年龄加速
- 批准号:
10614228 - 财政年份:2020
- 资助金额:
$ 194.24万 - 项目类别:
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy
时钟在滴答作响:表观遗传年龄加速作为妊娠期子宫功能的生物标志物
- 批准号:
10630244 - 财政年份:2020
- 资助金额:
$ 194.24万 - 项目类别: